ClinicalTrials.gg
CompletedNCT06138288Updated Jan 9, 2024

Acupressure Applied After Cesarean Section on Postpartum Pain

An observational study in Postpartum Disorder and Cesarean Section Complications, sponsored by Eastern Mediterranean University. Completed at 1 site in Cyprus. Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-09.

Sponsored by Eastern Mediterranean University · Observational

Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
60
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

Pressure applied according to the principles of acupressure limits the pain limit, reduces the secretion of endorphins, which is a neurochemical, reduces the tension in the muscles, reduces the amount of oxygen in the blood flow, and finally provides duration and relaxation. Acupressure application is becoming more and more common nowadays because it is a noninvasive, safe, easy-to-apply and effective method without side effects. It seems that there is a limit to the study in which group acupressure applications in the literature are examined together on pain and comfort after cesarean section. In these basic points, the expectations of achieving postpartum pain and postpartum comfort of acupressure applied after cesarean delivery in this study. The circle of the research; There will be women who will have repeated cesarean section in a private Obstetrics Clinic in Famagusta. Women will be separated from two groups, one group will continue acupressure and the other group will do routine care. Visual analog scale and end-of-birth comfort procedure will be applied to women before and after the application.

Read the detailed description

Pressure applied according to the principles of acupressure limits the pain limit, reduces the secretion of endorphins, which is a neurochemical, reduces the tension in the muscles, reduces the amount of oxygen in the blood flow, and finally provides duration and relaxation. Acupressure application is becoming more and more common nowadays because it is a noninvasive, safe, easy-to-apply and effective method without side effects. It seems that there is a limit to the study in which group acupressure applications in the literature are examined together on pain and comfort after cesarean section. In these basic points, the expectations of achieving postpartum pain and postpartum comfort of acupressure applied after cesarean delivery in this study. The circle of the research; There will be women who will have repeated cesarean section in a private Obstetrics Clinic in Famagusta. Women will be separated from two groups, one group will continue acupressure and the other group will do routine care. Visual analog scale and end-of-birth comfort procedure will be applied to women before and after the application.

02

Conditions studied

  • Postpartum Disorder
  • Cesarean Section Complications

Keywords

  • cesarean section
  • acupressure
  • postpartum
  • pain
  • postpartum comfort
03

In context

Puerperal Disorders

40 studies on the registry are indexed under Puerperal Disorders; 10 are open to participants now.

Browse Puerperal Disorders studies →

Lead sponsor

Eastern Mediterranean University is the lead sponsor of 141 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

18-49 age women

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • agreeing to participate in the research,
  • be between the ages of 18-49,
  • To give birth by cesarean section between 37-40 weeks,
  • Having a healthy and live birth at the end of a single pregnancy,
  • Receiving spinal anesthesia
  • Being able to read and write Turkish and be open to communication.

Exclusion criteria

Exclusion Criteria:

  • Absence of pain in the 2nd hour postpartum
  • Having a cesarean delivery after a risky pregnancy,
  • Having a chronic illness
  • Having severe systemic disease
  • Not receiving spinal anesthesia
  • Having a over 25,
  • Have previous acupressure experience.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
60 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • acupressure group

    Women who are in acupressure will apply the application after cesarean section 2nd hour after applying the data collection forms (descriptive features formula, VAS, WHO). For women on acupressure, the application will be applied manually to the SP6, P6 and L14 points in the order indicated by the drawing with the index or middle finger, 1-1.5 cm depth for 5 seconds, pressing for 5 seconds, resting for 2 seconds and continuing for 2 minutes to go. will be with you. VAS will be filled again after the application.

    Behavioral: acupressure

  • control group

Interventions

  • Behavioralacupressure

    The acupressure points to be used in the research are located on the inner side of the lower leg, 4 fingers above the ankle and on the spleen meridian behind the tibia (SP6), which was previously effective in reducing pain, and located three fingers above the wrist (in the middle of the 2nd metacarpal bone, on the dorsum of the hand, adjacent The points determined as P6 (located between the metacarpal bones) and LI4 located in the space between the thumb and index finger (between the 1st and 2nd metacarpal bones of the hand, in the middle of the 2nd metacarpal bone on the radial side) were applied by a certified researcher to women in the acupressure group. will be done

06

What researchers measure

Primary outcomes

  1. visual analog scale

    VAS has been developed to convert some values that cannot be measured numerically into numeric values. The VAS, which is a generally accepted, safe and easily applicable measurement tool in the world literature, consists of a 10 cm long line and there are subjective descriptive statements at both ends of the scale (0 cm = no pain and 10 cm = unbearable pain). The individual marks the appropriate place for his/her pain on this 10 cm line on the scale. The distance from the beginning of the scale to the point where the individual marks is measured with a ruler, and the pain intensity of the individual is determined numerically in cm. A low score obtained from the VAS indicates that the individual's pain intensity is low/low, and a high score indicates high/severe. The VAS is sensitive to pharmacological and non-pharmacological modalities that alter the pain experience.

    Time frame: 5 minutes

Secondary outcomes

  1. postpartum comfort scale

    It was developed by Karakaplan and Yıldız (2010) to determine postpartum comfort. The scale is likert type and consists of 34 items. Each item is scored between "strongly agree" (5 points), and "strongly disagree" (1 point). I totally agree with positive sentences shows the best comfort (5 points), and negative sentences show low comfort (1 point). Accordingly, the lowest score to be taken from the scale is 34, and the highest score is 170. The scale has three sub-dimensions as "physical, psychospiritual and sociocultural". An increase in the score obtained from the scale indicates an increase in comfort. The Cronbach Alpha reliability of the scale was found to be .78 for the total DSQ.

    Time frame: 15 minutes

07

Study locations

1 site
  • Hilal Begum Cayır
    Famagusta, 090, Cyprus
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2023 to primary completion in Dec 2023, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2023
First posted
Nov 18, 2023
StartActual
Nov 20, 2023
Primary completionActual
Dec 20, 2023
CompletionActual
Dec 30, 2023
Last update
Jan 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06138288
Responsible party
Hilal Begüm Çayır (Nurse, Eastern Mediterranean University) — Principal investigator
First posted
Nov 18, 2023
Start date
Nov 20, 2023
Primary completion
Dec 20, 2023
Completion
Dec 30, 2023
Last update
Jan 9, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion